Sun Pharmaceutical Industries Limited vs Rekvina Labs Ltd
A side-by-side comparison of Sun Pharmaceutical Industries Limited (SUNPHARMA) and Rekvina Labs Ltd (VINRKLB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Sun Pharmaceutical Industries Limited leads SUNPHARMA vs VINRKLB on 8 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability22
- Growth· not comparable—
- Size & financial health31
Valuation
SUNPHARMA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
- − ["Stock is trading at 5.00 times its book value"]
- + []
- − ["Company reported a net loss of ₹0 Cr in its latest financial year."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.